GeCIP Formation and Implementation Meeting Friday 19th June 2015
09:00 – 16:00 BST
The Royal Society, 6-9 Carlton House Terrace, London SW1Y 5AG
The purpose of this meeting is to define the goals and operations of the Genomics England Clinical Interpretation Partnership (GeCIP), the plans for establishing domains and current and future plans for funding activities.
In the afternoon there will be optional breakout sessions separated by domain category.
This meeting is open to GeCIP domain nominated leads, plus one nominated clinician or clinical scientist and one nominated academic researcher from each domain. As the venue has a limited capacity, we are unable to accommodate more than three representatives from each GeCIP domain.
Individuals attending this meeting must register here.
Prof Mark Caulfield
Chief Scientist Genomics England
Biographies of speakers
Professor Mark Caulfield
Chief Scientist, Genomics England
Mark graduated in Medicine in 1984 from the London Hospital Medical College and trained in Clinical Pharmacology at St Bartholomew’s Hospital, where he developed a research programme in molecular genetics of hypertension and clinical research. He is a Fellow of The Royal College of Physicians.
In 2000 Mark created the Barts and The London Genome Centre at the Queen Mary University of London. Since 2008 he has directed the Barts National Institute of Health Research (NIHR) Cardiovascular Biomedical Research Unit. Mark was appointed Director of the William Harvey Research Institute in 2002 and elected to the Academy of Medical Sciences in 2008. His particular areas of research are Cardiovascular Genomics and Translational Cardiovascular Research and Pharmacology. In 2013 he became an NIHR Senior Investigator.
Read full profile…